Cytokinetics CYTK Foreign currency translation gains (losses)
Foreign currency translation gains (losses) at other companies
Other financials
Where this comes from
Reported directly by Cytokinetics in its filing.
Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax.
The official record: Cytokinetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytokinetics's foreign currency translation gains (losses).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytokinetics's foreign currency translation gains (losses)?
- Cytokinetics (CYTK) reported foreign currency translation gains (losses) of -$404K in Q1 2026.
- How has Cytokinetics's foreign currency translation gains (losses) changed year-over-year?
- Cytokinetics's foreign currency translation gains (losses) decreased by 29.5% year-over-year, from -$312K to -$404K.
- What does foreign currency translation gains (losses) mean?
- The impact of changing currency exchange rates on the value of international assets.
- How do you interpret foreign currency translation gains (losses)?
- Positive values suggest a favorable currency movement, while negative values suggest an unfavorable impact on foreign holdings.
- How does foreign currency translation gains (losses) compare across companies?
- Standard for multinational corporations with operations in multiple currency zones.